HomeHealthcare & Life SciencesPharmaceuticals Arenavirus Infections Treatment Market

North America Arenavirus Infections Treatment Market Size & Outlook, 2026-2034


North America Arenavirus Infections Treatment Market Insights

  • As per Reed Intelligence insights, North America’s Arenavirus Infections Treatment Market was valued at USD 161.1 Million in 2025 and is anticipated to expand to USD 310.89 Million by 2034.
  • From 2026 to 2034, the market is anticipated to expand at a CAGR of 7.59%.
  • Within By Treatment Type, Antiviral Drugs accounted for the largest market size in 2025.
  • During the forecast period, Supportive Care is anticipated to remain the highest-growth segment within the By Treatment Type category.

Other Key Findings


  • In 2025, North America contributed 30.98% to the overall global Arenavirus Infections Treatment Market size.
  • By 2034, United States is anticipated to dominate the global market based on market size.
  • United States is expected to witness the fastest growth within North America, attaining USD 246.33 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 161.1 Million
Market Size In 2034 USD 310.89 Million
Largest segment Antiviral Drugs
Units Revenue in USD Million
CAGR 7.59% (2026-2034)
Segmnetation Covered
North America
  1. United States
  2. Canada
By Treatment Type
  1. Antiviral Drugs
  2. Supportive Care
  3. Combination Therapy
By Indication
  1. Lassa Fever
  2. Other Arenavirus Infections
  3. By Route of Administration
  4. Oral
  5. Intravenous
By End-Use
  1. Hospitals
  2. Specialty Treatment Centers
  3. Research Institutes
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports